ft 16 nov 93 london stock exchang smithklin activ two way tussl smithklin beecham yesterday critic press articl vie good news one compani product stock pressur select piec broker comment highlight sunday newspap articl suggest split mr bob bauman chief execut mr jan leschli chairman howev mani pharmaceut analyst felt differ opinion exagger beyond bound credibl one season observ said undoubtedli differ background differ person complet confid rift help stock statement compani say trial compar smithklin anti nausea compound kytril zofran rival product glaxo show kytril effect popular patient glaxo affect weekend report compani sack member sale forc follow intern investig mishandl compani fund share lost 12 642p smithklin finish 6 1 2 lower 402p ex dividend